文献速递肥胖与代谢综合征糖尿病

循环谷氨酸升高与亚临床动脉粥样硬化独立相关

Elevated Circulating Glutamate Is Associated With Subclinical Atherosclerosis Independently of Established Risk Markers: A Cross-Sectional Study.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

横断面研究纳入102名精确表型分析个体,测定血浆谷氨酸与支链氨基酸水平,并评估体脂分布、肝脏脂肪含量、胰岛素敏感性与颈动脉内膜中层厚度。结果显示,校正年龄、性别、体脂及内脏脂肪后,谷氨酸仍与cIMT正相关,且独立于肝脏脂肪、胰岛素敏感性和支链氨基酸;IL-6可能部分介导该关联。

要点

  • 校正年龄、性别、体脂和内脏脂肪后,谷氨酸与cIMT正相关(std β≥.22,P≤.023)。
  • 谷氨酸与cIMT的关联独立于肝脏脂肪含量、胰岛素敏感性和支链氨基酸(std β≥.24,P≤.02)。
  • IL-6对谷氨酸与cIMT关联的衰减作用最强(std β=.28,P=.05),提示亚临床炎症可能参与。

核心结论

  • 血浆谷氨酸升高与cIMT增加相关,且独立于已确立的心血管疾病危险因素。
  • 该关联可能部分由IL-6相关的亚临床炎症解释。

研究设计与样本

  • 横断面研究,纳入102名经精确表型分析的个体。
  • 体脂质量与分布用磁共振成像评估,肝脏脂肪含量用1H-磁共振波谱评估。
  • 胰岛素敏感性通过口服葡萄糖耐量试验和高胰岛素-正常血糖钳夹评估(钳夹N=57)。
  • 颈动脉内膜中层厚度(cIMT)作为亚临床动脉粥样硬化指标。

主要发现

  • 校正年龄、性别、体脂质量和内脏脂肪质量后,谷氨酸与肝脏脂肪含量及cIMT正相关(所有std β≥.22,所有P≤.023),与胰岛素敏感性负相关(std β≤-.31,P≤.002)。
  • 进一步校正肝脏脂肪含量、胰岛素敏感性和支链氨基酸后,谷氨酸仍与cIMT相关(std β≥.24,P≤.02)。
  • 观察到谷氨酸与IL-6独立正相关(N=50;std β=.39,P=.03)。
  • 在该亚组中,校正年龄、性别、体脂质量和内脏脂肪质量后谷氨酸与cIMT正相关(std β=.31,P=.02)。
  • 进一步校正肝脏脂肪含量、胰岛素敏感性、支链氨基酸或IL-6后,校正IL-6对上述关系的衰减最强(std β=.28,P=.05)。

临床怎么用

  • 在评估亚临床动脉粥样硬化风险时,可关注循环谷氨酸水平及其与IL-6相关炎症的关联。
  • 谷氨酸与cIMT的独立关联提示其可能作为超越传统危险因素的附加标记,但尚需进一步验证。

局限性

  • 为横断面研究,无法推断因果关系。
  • 样本量有限(102人,部分分析N=57或N=50)。
  • 单中心精确表型研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Elevated plasma glutamate levels are associated with an increased risk of cardiovascular disease (CVD). Because plasma glutamate levels are also strongly associated with visceral adiposity, nonalcoholic fatty liver disease, insulin resistance, and high circulating levels of branched-chain amino acids (BCAAs), it is unknown to what extent elevated circulating glutamate is an independent marker of an increased risk of atherosclerosis. METHODS: Plasma levels of glutamate and BCAAs were measured in 102 individuals who were precisely phenotyped for body fat mass and distribution (magnetic resonance [MR] tomography), liver fat content (1H-MR spectroscopy), insulin sensitivity (oral glucose tolerance test and hyperinsulinemic, euglycemic clamp [N = 57]), and carotid intima media thickness (cIMT). RESULTS: Plasma glutamate levels, adjusted for age, sex, body fat mass, and visceral fat mass, correlated positively with liver fat content and cIMT (all std β ≥ .22, all P ≤ .023) and negatively with insulin sensitivity (std β ≤ -.31, P ≤ .002). Glutamate levels also were associated with cIMT, independently of additional adjustment for liver fat content, insulin sensitivity and BCAAs levels (std β ≥ .24, P ≤ .02). Furthermore, an independent positive association of glutamate and interleukin-6 (IL-6) levels was observed (N = 50; std β = .39, P = .03). Although glutamate, adjusted for age, sex, body fat mass, and visceral fat mass, also correlated positively with cIMT in this subgroup (std β = .31, P = .02), after additional adjustment for the parameters liver fat content, insulin sensitivity, BCAAs, or IL-6 levels, adjustment for IL-6 most strongly attenuated this relationship (std β = .28, P = .05). CONCLUSIONS: Elevated plasma glutamate levels are associated with increased cIMT, independently of established CVD risk factors, and this relationship may in part be explained by IL-6-associated subclinical inflammation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lehn-Stefan A, Peter A, Machann J, et al. Elevated Circulating Glutamate Is Associated With Subclinical Atherosclerosis Independently of Established Risk Markers: A Cross-Sectional Study. J Clin Endocrinol Metab. 2021. PMID: 33277657. doi:10.1210/clinem/dgaa898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。